IAPP and type 2 diabetes mellitus: Promising results from human Amylin transgenic mice, in which rutin delivered orally in drinking water delayed development of T2D [21,31], led us to test the effect of rutin supplementation on a cohort of overweight normoglycaemic and prediabetic individuals.